UK markets closed

Black Diamond Therapeutics, Inc. (BDTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.11-0.64 (-9.48%)
At close: 04:00PM EDT
5.75 -0.36 (-5.89%)
After hours: 05:46PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-82,442
-82,442
-91,169
-125,596
-67,254
Depreciation & amortisation
437
437
508
205
52
Stock-based compensation
9,604
9,604
12,197
14,037
7,765
Change in working capital
3,686
3,686
-9,901
7,020
5,042
Accounts payable
597
597
-2,230
1,569
1,069
Other working capital
-66,750
-66,750
-85,274
-102,858
-52,288
Other non-cash items
2,814
2,814
2,730
2,007
548
Net cash provided by operating activities
-66,717
-66,717
-85,082
-100,148
-52,146
Cash flows from investing activities
Investments in property, plant and equipment
-33
-33
-192
-2,710
-142
Purchases of investments
-61,887
-61,887
-60,141
-49,508
-372,477
Sales/maturities of investments
78,171
78,171
113,690
182,831
90,928
Net cash used for investing activities
16,346
16,346
53,366
130,613
-281,691
Cash flows from financing activities
Common stock issued
71,850
71,850
0
0
213,844
Net cash used provided by (used for) financing activities
71,932
71,932
177
729
214,944
Net change in cash
21,561
21,561
-31,539
31,194
-118,893
Cash at beginning of period
35,483
35,483
67,022
35,828
154,721
Cash at end of period
57,044
57,044
35,483
67,022
35,828
Free cash flow
Operating cash flow
-66,717
-66,717
-85,082
-100,148
-52,146
Capital expenditure
-33
-33
-192
-2,710
-142
Free cash flow
-66,750
-66,750
-85,274
-102,858
-52,288